Dr. Ivana Magovcevic-Liebisch - Dyax
Dyax will wave a fond farewell to Dr. Ivana Magovcevic-Liebisch after 12 years with the biopharmaceutical company in the role of Executive Vice President, Chief Operating Officer.
She will continue to serve as a consultant to Dyax but leaves to pursue a senior management opportunity at a multinational pharmaceutical company which she will begin at the end of the month, so keep reading this column to find out where!